Skip to main content
OpenTrials
Completed

NCT Number: NCT00029614

Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivity Disorder (ADHD).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Use Disorders Attention Deficit Disorder with Hyperactivity Attention Deficit Hyperactivity Disorder Attention Deficit and Disruptive Behavior Disorders Chemically-Induced Disorders Mental Disorders Neurodevelopmental Disorders Substance-Related Disorders

Age range

13 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Western Psychiatric Institute and Clinic

Pittsburgh, Pennsylvania, 15213, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adolescents, ages 13-18
  • Meets criteria for alcohol and/or substance use disorder and attention deficit hyperactivity disorder.

Exclusion criteria

  • Adolescents who are pregnant.
  • Have a history of seizure disorder, other neurological or medical disorder for which medication treatment may present a considerable risk.
  • History of pervasive development disorder, schizophrenia or other psychotic disorders, organic mental disorders or eating disorders.
  • Currently on other psychotropic medications from which discontinuation would present a significant risk.
  • A current episode of major depressive disorder or a diagnosis of bipolar disorder.
  • Diagnosis of dependence for any substance other than marijuana.
  • Adolescents with a full-scale IQ below 80.

Treatment and study plan

Atomoxetine

Drug

Primary outcomes

  1. decrease in ADHD symptoms

  2. decrease in the quantity and frequency of alcohol and other substance use

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Registry information

Official study title

Psychopharmacology of Adolescents With AUD and ADHD

Important dates

Study start
2006
Study completion
2007
First posted
Jan 17, 2002
Registry last updated
Apr 28, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.